72
Overbought
Moving averages
SMA 200$223.75+48.39%
Company profile
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$45.89B
P/E ratioNone
EPS$-1.34
Beta1.514
Dividend yield0.00%
52-week high$326.03
52-week low$152.62
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 75
ILMN
Illumina Inc
RSI 70
MTD
Mettler-Toledo International Inc
RSI 54
CSTL
Castle Biosciences Inc
RSI 71
FONR
Fonar Corp
RSI 75
CRL
Charles River Laboratories International Inc
RSI 76
BDSX
Biodesix Inc
RSI 64
WGS
GeneDx Holdings Corp - Class A
RSI 71
DGX
Quest Diagnostics Inc
RSI 36
NEO
Neogenomics Inc
RSI 35
RSI alerts for NTRA
Get an email the moment Natera Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 8:44 AM EDT